4.18
price down icon1.65%   -0.07
 
loading

Finanzdaten der Agenus Inc-Aktie (AGEN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
6.75%
25.69
24.07 26.84 25.11 23.51
Cost Of Revenue
77.37%
0.243
0.137 0.118 0.146 0.115
Gross Profit
6.35%
25.45
23.93 26.72 24.97 23.39
Operating Expenses
13.21%
42.16
37.24 52.62 56.47 53.59
Benefits Costs and Expenses
10.44%
55.70
50.44 73.64 92.33 78.31
Costs And Expenses
10.44%
55.70
50.44 73.64 92.33 78.31
Operating Income/Loss
25.54%
-16.71
-13.31 -25.90 -31.50 -30.19
Nonoperating Income/Loss
95.45%
-0.012
-0.264 -0.224 0.019 7.141
Income/Loss From Continuing Operations Before Tax
13.81%
-30.01
-26.37 -46.81 -67.21 -54.80
Income/Loss From Continuing Operations After Tax
13.81%
-30.01
-26.37 -46.81 -67.21 -54.80
Net Income/Loss
13.81%
-30.01
-26.37 -46.81 -67.21 -54.80
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-2.057
- -0.947 -0.828 -1.716
Basic Average Shares
1,650%
28.12
-1.814 0.478 21.55 21.06
Diluted Average Shares
1,650%
28.12
-1.814 0.478 21.55 21.06
Basic Earnings Per Share
2.91%
-1.00
-1.03 -1.94 -3.08 -2.52
Diluted Earnings Per Share
2.91%
-1.00
-1.03 -1.94 -3.08 -2.52
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.87
price down icon 0.96%
$84.61
price up icon 1.09%
$23.70
price down icon 2.95%
$100.00
price down icon 1.89%
$136.10
price up icon 0.84%
biotechnology ONC
$306.05
price up icon 2.72%
Kapitalisierung:     |  Volumen (24h):